D. M. Musher

1.1k total citations
23 papers, 802 citations indexed

About

D. M. Musher is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, D. M. Musher has authored 23 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Pharmacology. Recurrent topics in D. M. Musher's work include Pneumonia and Respiratory Infections (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). D. M. Musher is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). D. M. Musher collaborates with scholars based in United States and Italy. D. M. Musher's co-authors include R E Baughn, David Watson, Maria C. Rodriguez‐Barradas, Sune Thorsteinsson, Donald P. Griffith, Edward A. Graviss, Roger D. Rossen, David H. Yawn, Rahul Sampath and Gordon Crofoot and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

D. M. Musher

23 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. M. Musher United States 15 452 176 113 92 90 23 802
Robert M. Bannatyne Canada 19 476 1.1× 388 2.2× 95 0.8× 74 0.8× 80 0.9× 80 1.1k
Jonas A. Shulman United States 14 258 0.6× 168 1.0× 96 0.8× 52 0.6× 68 0.8× 27 704
Glenn R. Hodges United States 16 311 0.7× 175 1.0× 44 0.4× 71 0.8× 110 1.2× 44 807
David Huminer Israel 17 291 0.6× 174 1.0× 44 0.4× 88 1.0× 53 0.6× 29 740
R. B. Ellis‐Pegler New Zealand 17 335 0.7× 360 2.0× 97 0.9× 105 1.1× 82 0.9× 66 1.1k
Jen-Hsien Wang Taiwan 12 445 1.0× 149 0.8× 87 0.8× 47 0.5× 100 1.1× 18 748
G. M. Kalmanson United States 16 376 0.8× 216 1.2× 85 0.8× 185 2.0× 77 0.9× 69 993
George J. Pazin United States 19 719 1.6× 408 2.3× 183 1.6× 114 1.2× 105 1.2× 36 1.3k
J. Thomas Grayston United States 7 728 1.6× 91 0.5× 71 0.6× 64 0.7× 61 0.7× 8 1.0k
Toshihiro Mitsuda Japan 14 215 0.5× 206 1.2× 60 0.5× 82 0.9× 45 0.5× 54 676

Countries citing papers authored by D. M. Musher

Since Specialization
Citations

This map shows the geographic impact of D. M. Musher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. M. Musher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. M. Musher more than expected).

Fields of papers citing papers by D. M. Musher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. M. Musher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. M. Musher. The network helps show where D. M. Musher may publish in the future.

Co-authorship network of co-authors of D. M. Musher

This figure shows the co-authorship network connecting the top 25 collaborators of D. M. Musher. A scholar is included among the top collaborators of D. M. Musher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. M. Musher. D. M. Musher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abers, Michael S. & D. M. Musher. (2014). Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics. QJM. 107(7). 595–596. 16 indexed citations
2.
Farmakiotis, Dimitrios, et al.. (2013). Photo Quiz: To Scan or Not to Scan?. Clinical Infectious Diseases. 56(7). 1052–1053. 1 indexed citations
3.
Graviss, Edward A., et al.. (2012). Acute kidney injury associated with trimethoprim/sulfamethoxazole. Journal of Antimicrobial Chemotherapy. 67(5). 1271–1277. 80 indexed citations
4.
Zylla, Dylan M., Kelly Cawcutt, D. M. Musher, et al.. (2012). Pneumococcal Pyomyositis: Report of 2 Cases and Review of the Literature. Clinical Infectious Diseases. 55(3). e12–e17. 8 indexed citations
5.
Musher, D. M., Rahul Sampath, & Maria C. Rodriguez‐Barradas. (2011). The Potential Role for Protein-Conjugate Pneumococcal Vaccine in Adults: What Is the Supporting Evidence?. Clinical Infectious Diseases. 52(5). 633–640. 53 indexed citations
6.
Musher, D. M., et al.. (2011). Severe Pulmonary Involvement in a Case Attributed to Domestically Acquired Seoul Hantavirus in the United States. Clinical Infectious Diseases. 54(1). 91–94. 14 indexed citations
7.
Amendola, A., Elisabetta Tanzi, Alessandra Zappá, et al.. (2002). Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Vaccine. 20(31-32). 3720–3724. 28 indexed citations
8.
Musher, D. M., et al.. (1999). A brief history of the pneumococcus in biomedical research.. PubMed. 14(3). 198–208. 21 indexed citations
9.
Musher, D. M., et al.. (1993). An analysis of sources of measurement variation in ELISA and a simple method for identification of outliers among replicate data. Serodiagnosis and Immunotherapy in Infectious Disease. 5(2). 71–75. 2 indexed citations
10.
Musher, D. M., et al.. (1993). Assessment of responses to pneumococcal infection and vaccination using enzyme-linked immunoassay. Serodiagnosis and Immunotherapy in Infectious Disease. 5(3). 131–133. 3 indexed citations
11.
Rodriguez‐Barradas, Maria C., D. M. Musher, Christine E. Lacke, et al.. (1992). Antibody to Capsular Polysaccharides of Streptococcus pneumoniae after Vaccination of Human Immunodeficiency Virus-Infected Subjects with 23-Valent Pneumococcal Vaccine. The Journal of Infectious Diseases. 165(3). 553–556. 113 indexed citations
12.
Musher, D. M.. (1991). Pneumococcal Pneumonia Including Diagnosis and Therapy of Infection Caused by Penicillin-Resistant Strains. Infectious Disease Clinics of North America. 5(3). 509–521. 20 indexed citations
13.
Darouiche, Rabih O., Bradley A. Perkins, D. M. Musher, Richard J. Hamill, & S.F. Tsai. (1990). Levels of Rifampin and Ciproftoxacin in Nasal Secretions: Correlation with MIC90 and Eradication of Nasopharyngeal Carriage of Bacteria. The Journal of Infectious Diseases. 162(5). 1124–1127. 32 indexed citations
14.
Musher, D. M., David Watson, & R E Baughn. (1990). Does Naturally Acquired IgG Antibody to Cell Wall Polysaccharide Protect Human Subjects against Pneumococcal Infection?. The Journal of Infectious Diseases. 161(4). 736–740. 82 indexed citations
15.
Musher, D. M.. (1987). Syphilis.. PubMed. 1(1). 83–95. 1 indexed citations
16.
Clarridge, Jill E., Catherine Roberts, John Peters, & D. M. Musher. (1983). Sepsis and empyema caused by Yersinia enterocolitica. Journal of Clinical Microbiology. 17(5). 936–938. 11 indexed citations
17.
Musher, D. M.. (1980). Cutaneous and Soft-Tissue Manifestations of Sepsis Due to Gram-Negative Enteric Bacilli. Clinical Infectious Diseases. 2(6). 854–866. 68 indexed citations
18.
Musher, D. M., et al.. (1977). Emergence of Variant Forms of Staphylococcus aureus after Exposure to Gentamicin and Infectivity of the Variants in Experimental Animals. The Journal of Infectious Diseases. 136(3). 360–369. 70 indexed citations
19.
Musher, D. M., et al.. (1976). Inhibition of the Antibacterial Activity of Gentamicin by Urine. The Journal of Infectious Diseases. 133(1). 14–21. 64 indexed citations
20.
Musher, D. M., Donald P. Griffith, David H. Yawn, & Roger D. Rossen. (1975). Role of Urease in Pyelonephritis Resulting from Urinary Tract Infection with Proteus. The Journal of Infectious Diseases. 131(2). 177–181. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026